<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel>
  <title>MolWard Knowledge Base</title>
  <link>https://www.molward.com/knowledge.html</link>
  <description>Articles, guides and case studies on stability, degradation, nitrosamine/ICH M7 toxicology and method validation.</description>
  <language>en-us</language>
  <atom:link href="https://www.molward.com/knowledge-feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>From Animal NOAEL to First-in-Human: Calculating the HED and Maximum Recommended Starting Dose</title>
      <link>https://www.molward.com/knowledge-hed-mrsd-human-equivalent-dose-first-in-human-starting-dose.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-hed-mrsd-human-equivalent-dose-first-in-human-starting-dose.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Sun, 12 Jul 2026 09:00:00 +0000</pubDate>
      <description>How the FDA body-surface-area Km ratio converts an animal dose to the Human Equivalent Dose, and how the safety factor turns it into a defensible Maximum Recommended Starting Dose for a first-in-human trial.</description>
    </item>
    <item>
      <title>How Random Forest QSAR Is Revolutionizing Early-Stage Genotox Screening</title>
      <link>https://www.molward.com/knowledge-random-forest-qsar-early-genotox-screening.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-random-forest-qsar-early-genotox-screening.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Sat, 11 Jul 2026 09:00:00 +0000</pubDate>
      <description>How Random Forest algorithms reason over chemical topology, and why 2048-bit Morgan fingerprints trained on curated Hansen/ECVAM datasets beat legacy methods on ROC-AUC.</description>
    </item>
    <item>
      <title>Beyond the &quot;Black Box&quot;: Why Regulatory Agencies Demand Mechanistic Transparency</title>
      <link>https://www.molward.com/knowledge-beyond-the-black-box-regulatory-mechanistic-transparency.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-beyond-the-black-box-regulatory-mechanistic-transparency.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Fri, 10 Jul 2026 09:00:00 +0000</pubDate>
      <description>Why deep-learning models fail regulatory scrutiny without mechanistic explanations — and how ICH M7&#x27;s dual expert-rule-plus-statistical architecture keeps AI-assisted toxicology defensible.</description>
    </item>
    <item>
      <title>Your First Stability Study Is Preformulation: Predicting Solid-State and Degradation Risk from the Molecule</title>
      <link>https://www.molward.com/knowledge-preformulation-predicting-solid-state-and-degradation-risk.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-preformulation-predicting-solid-state-and-degradation-risk.html</guid>
      <category>Stability &amp; Degradation</category>
      <pubDate>Thu, 09 Jul 2026 09:00:00 +0000</pubDate>
      <description>Salt, polymorph and hygroscopicity choices made in preformulation quietly pre-programme your degradation profile — how to see the liabilities in silico before you commit the crystal form.</description>
    </item>
    <item>
      <title>Reporting, Identification, Qualification: Setting Impurity Limits That Survive Review</title>
      <link>https://www.molward.com/knowledge-setting-impurity-limits-ich-q3a-q3b-reporting-identification-qualification.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-setting-impurity-limits-ich-q3a-q3b-reporting-identification-qualification.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Wed, 08 Jul 2026 09:00:00 +0000</pubDate>
      <description>The ICH Q3A(R2)/Q3B(R2) dose-scaled threshold ladder, where the ICH M7 mutagenicity overlay overrides it, and how to justify each limit before an assessor asks.</description>
    </item>
    <item>
      <title>From Microcapsule to Specification: Dissolution as the Control Strategy for Modified-Release Products</title>
      <link>https://www.molward.com/knowledge-modified-release-dissolution-f2-similarity-control-strategy.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-modified-release-dissolution-f2-similarity-control-strategy.html</guid>
      <category>R&amp;D Strategy</category>
      <pubDate>Tue, 07 Jul 2026 09:00:00 +0000</pubDate>
      <description>A modified-release product&#x27;s clinical behaviour lives in its release curve — how the f2 similarity factor turns that formulation fingerprint into a defensible, biowaiver-ready control strategy.</description>
    </item>
    <item>
      <title>Stability-Indicating Methods (SIM): A Predictive Roadmap for Analytical Scientists</title>
      <link>https://www.molward.com/knowledge-stability-indicating-methods-sim-a-predictive-roadmap-for-analytical-chemists.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-stability-indicating-methods-sim-a-predictive-roadmap-for-analytical-chemists.html</guid>
      <category>Stability &amp; Degradation</category>
      <pubDate>Wed, 18 Mar 2026 09:00:00 +0000</pubDate>
      <description>Why waiting for a three-month stability pull to start method development is a business risk — and how to map the separation space before the first blank.</description>
    </item>
    <item>
      <title>The &quot;Cohort of Concern&quot;: A Guide to High-Risk Structures</title>
      <link>https://www.molward.com/knowledge-the-cohort-of-concern-a-guide-to-high-risk-structures.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-the-cohort-of-concern-a-guide-to-high-risk-structures.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Fri, 13 Mar 2026 09:00:00 +0000</pubDate>
      <description>The three structural classes that lose the 1.5 µg/day safe harbour — and the process and excipient triggers that quietly generate them.</description>
    </item>
    <item>
      <title>Case Study — Predicting Late-Stage Nitrosamine Degradation and Automating CPCA Scoring: A Retrospective In Silico Analysis of Ranitidine</title>
      <link>https://www.molward.com/knowledge-study-case-predicting-late-stage-nitrosamine-degradation-and-automating-cpca-scoring-a-retrospect.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-study-case-predicting-late-stage-nitrosamine-degradation-and-automating-cpca-scoring-a-retrospect.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Thu, 12 Mar 2026 09:00:00 +0000</pubDate>
      <description>A retrospective look at the Zantac/NDMA recall: what a 43-second in silico scan would have flagged on Day 1.</description>
    </item>
    <item>
      <title>ICH M7(R2) Compliance: When Do You Actually Need an Ames Test?</title>
      <link>https://www.molward.com/knowledge-ich-m7-r2-compliance-when-do-you-actually-need-an-ames-test.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-ich-m7-r2-compliance-when-do-you-actually-need-an-ames-test.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Wed, 11 Mar 2026 09:00:00 +0000</pubDate>
      <description>A risk-based read of the Class 1–5 framework, and how a dual-methodology in silico assessment lets you defensibly skip the wet lab.</description>
    </item>
    <item>
      <title>Navigating the 2024 FDA Nitrosamine Guidance: Automating CPCA Limits</title>
      <link>https://www.molward.com/knowledge-navigating-the-2024-fda-nitrosamine-guidance-automating-cpca-limits.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-navigating-the-2024-fda-nitrosamine-guidance-automating-cpca-limits.html</guid>
      <category>Toxicology &amp; Safety</category>
      <pubDate>Sat, 07 Mar 2026 09:00:00 +0000</pubDate>
      <description>Decoding the Carcinogenic Potency Categorization Approach — and why manual α-hydrogen counting is a costly place to make an error.</description>
    </item>
    <item>
      <title>Building a Predictive-First Culture in Pharmaceutical R&amp;D</title>
      <link>https://www.molward.com/knowledge-building-a-predictive-first-culture-in-pharmaceutical-r-d.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-building-a-predictive-first-culture-in-pharmaceutical-r-d.html</guid>
      <category>R&amp;D Strategy</category>
      <pubDate>Wed, 25 Feb 2026 09:00:00 +0000</pubDate>
      <description>Breaking down the wall between computational chemistry, formulation and the analytical lab with a single source of molecular truth.</description>
    </item>
    <item>
      <title>How to Calculate Precision and Intermediate Precision in Method Validation</title>
      <link>https://www.molward.com/knowledge-how-to-calculate-precision-and-intermediate-precision-in-method-validation.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-how-to-calculate-precision-and-intermediate-precision-in-method-validation.html</guid>
      <category>Method Validation</category>
      <pubDate>Fri, 16 Jan 2026 09:00:00 +0000</pubDate>
      <description>Repeatability, intermediate precision, %RSD and the ANOVA F-test — the statistics that prove your stability data isn&#x27;t just analytical noise.</description>
    </item>
    <item>
      <title>How to Calculate Accuracy in Method Validation</title>
      <link>https://www.molward.com/knowledge-how-to-calculate-accuracy-in-method-validation.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-how-to-calculate-accuracy-in-method-validation.html</guid>
      <category>Method Validation</category>
      <pubDate>Thu, 15 Jan 2026 09:00:00 +0000</pubDate>
      <description>Recovery studies, the three-level spiking protocol, and correcting impurity quantitation with Relative Response Factors.</description>
    </item>
    <item>
      <title>Mass Balance in Pharmaceutical Analysis: A Critical Stability Indicator</title>
      <link>https://www.molward.com/knowledge-mass-balance-in-pharmaceutical-analysis-a-critical-stability-indicator.html</link>
      <guid isPermaLink="true">https://www.molward.com/knowledge-mass-balance-in-pharmaceutical-analysis-a-critical-stability-indicator.html</guid>
      <category>Stability &amp; Degradation</category>
      <pubDate>Thu, 15 Jan 2026 09:00:00 +0000</pubDate>
      <description>The AMBD and RMBD deficits, the five failing modes behind missing mass, and what regulators actually expect you to investigate.</description>
    </item>
</channel></rss>
